Mereo BioPharma Group PLCNASDAQ:MREO
- LAST PRICE4.3400
- TODAY'S CHANGE (%)0.3500 (8.7719%)
- Bid / Lots4.3400/ 5
- Ask / Lots4.3500/ 8
- Open / Previous Close4.0000 / 3.9900
- Day Range
- 52 Week Range
- Volume3,723,588
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MREO |
|---|---|---|
| 09:32 ET | 154943 | 4.18 |
| 09:34 ET | 108363 | 4.175 |
| 09:36 ET | 68624 | 4.16 |
| 09:38 ET | 57802 | 4.165 |
| 09:39 ET | 33488 | 4.155 |
| 09:41 ET | 60982 | 4.15 |
| 09:43 ET | 139666 | 4.205 |
| 09:45 ET | 124534 | 4.2001 |
| 09:48 ET | 23344 | 4.215 |
| 09:50 ET | 98445 | 4.2 |
| 09:52 ET | 31800 | 4.24 |
| 09:54 ET | 14770 | 4.22 |
| 09:56 ET | 16140 | 4.2 |
| 09:57 ET | 32444 | 4.215 |
| 09:59 ET | 120707 | 4.2 |
| 10:01 ET | 68803 | 4.2199 |
| 10:03 ET | 109781 | 4.27 |
| 10:06 ET | 65772 | 4.27 |
| 10:08 ET | 13193 | 4.255 |
| 10:10 ET | 44375 | 4.1861 |
| 10:12 ET | 47625 | 4.175 |
| 10:14 ET | 70419 | 4.255 |
| 10:15 ET | 10700 | 4.23 |
| 10:17 ET | 26776 | 4.215 |
| 10:19 ET | 17273 | 4.195 |
| 10:21 ET | 41381 | 4.195 |
| 10:24 ET | 111358 | 4.185 |
| 10:26 ET | 46204 | 4.16 |
| 10:28 ET | 53724 | 4.175 |
| 10:30 ET | 9334 | 4.18 |
| 10:32 ET | 12975 | 4.145 |
| 10:33 ET | 26870 | 4.155 |
| 10:35 ET | 28434 | 4.145 |
| 10:37 ET | 9521 | 4.17 |
| 10:39 ET | 18585 | 4.1501 |
| 10:42 ET | 31470 | 4.155 |
| 10:44 ET | 34371 | 4.142 |
| 10:46 ET | 25113 | 4.145 |
| 10:48 ET | 4212 | 4.1499 |
| 10:50 ET | 7068 | 4.1599 |
| 10:51 ET | 21272 | 4.165 |
| 10:53 ET | 2384 | 4.165 |
| 10:55 ET | 19995 | 4.135 |
| 10:57 ET | 41914 | 4.135 |
| 11:00 ET | 92326 | 4.135 |
| 11:02 ET | 9533 | 4.1422 |
| 11:04 ET | 1145 | 4.145 |
| 11:06 ET | 13690 | 4.1444 |
| 11:08 ET | 67055 | 4.15 |
| 11:09 ET | 31718 | 4.17 |
| 11:11 ET | 16476 | 4.185 |
| 11:13 ET | 16698 | 4.225 |
| 11:15 ET | 53728 | 4.235 |
| 11:18 ET | 58999 | 4.245 |
| 11:20 ET | 43485 | 4.24 |
| 11:22 ET | 20304 | 4.25 |
| 11:24 ET | 29095 | 4.25 |
| 11:26 ET | 4978 | 4.25 |
| 11:27 ET | 33597 | 4.2702 |
| 11:29 ET | 31070 | 4.255 |
| 11:31 ET | 7433 | 4.295 |
| 11:33 ET | 15327 | 4.295 |
| 11:36 ET | 69725 | 4.295 |
| 11:38 ET | 29128 | 4.28 |
| 11:40 ET | 23085 | 4.28 |
| 11:42 ET | 53785 | 4.28 |
| 11:44 ET | 3279 | 4.295 |
| 11:45 ET | 36080 | 4.3 |
| 11:47 ET | 24433 | 4.27 |
| 11:49 ET | 74999 | 4.24 |
| 11:51 ET | 3276 | 4.245 |
| 11:54 ET | 4739 | 4.255 |
| 11:56 ET | 26725 | 4.27 |
| 11:58 ET | 4255 | 4.27 |
| 12:00 ET | 1529 | 4.275 |
| 12:02 ET | 193175 | 4.28 |
| 12:03 ET | 2124 | 4.29 |
| 12:05 ET | 2428 | 4.2899 |
| 12:07 ET | 22357 | 4.37 |
| 12:09 ET | 38329 | 4.36 |
| 12:12 ET | 20438 | 4.3957 |
| 12:14 ET | 30510 | 4.4 |
| 12:16 ET | 13473 | 4.375 |
| 12:18 ET | 6255 | 4.3799 |
| 12:20 ET | 1900 | 4.38 |
| 12:21 ET | 3567 | 4.3699 |
| 12:23 ET | 10214 | 4.3499 |
| 12:25 ET | 2384 | 4.35 |
| 12:27 ET | 40949 | 4.34 |
Today
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 4 hours ago by Dow Jones
4 hours ago by Dow JonesPress Release: Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market, from 4 hours ago by Dow Jones
4 hours ago by Dow Jones
Yesterday
DJ Mereo BioPharma Group Initiated at Outperform by Baird, from 5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
5:27AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 12, 2024
DJ Mereo BioPharma Group Price Target Maintained With a $7.00/Share by Cantor Fitzgerald, from 12:25PM ET on Wednesday Jun 12, 2024 by Dow Jones
12:25PM ET on Wednesday Jun 12, 2024 by Dow JonesDJ Mereo BioPharma Group Is Maintained at Buy by Needham, from 6:47AM ET on Wednesday Jun 12, 2024 by Dow Jones
6:47AM ET on Wednesday Jun 12, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Mereo BioPharma Group PLC | 537.2M | -16.2x | --- |
ProKidney Corp | 692.8M | -5.0x | --- |
Zentalis Pharmaceuticals Inc | 695.2M | -2.7x | --- |
Lexicon Pharmaceuticals Inc | 690.4M | -2.2x | --- |
Aerovate Therapeutics Inc | 663.2M | -8.1x | --- |
Lyell Immunopharma Inc | 652.6M | -2.6x | --- |
Company Information
Mereo BioPharma Group plc is a biopharmaceutical company. It is focused on the development of therapeutics for rare diseases. It has developed a portfolio of clinical-stage product candidates. The Company has two rare disease product candidates: setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat for the treatment of severe alpha-1-antitrypsin deficiency-associated lung disease (AATD-LD) and bronchiolitis obliterans syndrome (BOS). It also has two oncology product candidates in clinical development. It also includes Etigilimab, an antibody against TIGIT (T-cell immunoreceptor with Ig and ITIM domains). Its non-core partnered programme, Navicixizumab, is a bispecific antibody that inhibits delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF). Its non-core programs available for partnership include Acumapimod and Leflutrozole. Acumapimod is a p38 MAP kinase inhibitor therapy for treatment during severe acute exacerbations of COPD (AECOPD).
Contact Information
- Headquarters
- One Cavendish Place, Fourth FloorLONDON, United Kingdom W1G0QF
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Director
- Michael Wyzga
- Chief Executive Officer, Director
- Denise Scots-Knight
- Chief Financial Officer
- Christine Fox
- Senior Vice President - Clinical Development
- Suba Krishnan
- Senior Vice President - Therapeutic Head
- Jackie Parkin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $537.2M |
|---|---|
Revenue (TTM) | $9.1M |
Shares Outstanding | 140.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.90 |
EPS | $-0.27 |
Book Value | $0.63 |
P/E Ratio | -16.2x |
Price/Sales (TTM) | 58.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -444.28% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
